Datasets (31,150)

Circadian rhythm-dependent programs control inflammatory responses and drug metabolism in primary human hepatocytes II.

A progesterone derivative linked to a stable phospholipid activates breast cancer cell response without leaving the cell membrane

LATS1/2 Loss Promote Tumor Immune Evasion in Endometrial Cancer through Downregulating MHC-I Expression

Epigenomic Analyses Identify FOXM1 As a Key Regulator of Anti-Tumor Immune Response in Esophageal Adenocarcinoma

Whole blood transcriptomics reveals G-CSF as a mediator of cardiopulmonary bypass- induced systemic inflammatory response syndrome

Stranded bulk Illumina RNASeq of human mammary tumors before and after neoadjuvant chemotherapy treatment

The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1

Transcriptomic Profiling for Prognostic Biomarkers in Early-stage Squamous Cell Lung Cancer (SqCLC)

RNA-seq analysis of HeLa cells infected with VSV-GFP in presence or absence of NP-neuvir.

Phase separation of N-myc differentially modulates the transcriptom

The effects of Eupalinolide B on PANC-1 cells.

Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine

PGCC development and recovery within a prostate cancer cell population

TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells

Systematic analyses of RNA-binding proteins uncover therapeutically promising vulnerabilities in osteosarcoma